Pharmacogenetics guided anticoagulation. - Wikidata - wikimedia - TriplyDB

Pharmacogenetics guided anticoagulation.

Pharmacogenetics guided anticoagulation.

http://www.wikidata.org/entity/Q37808224

about

Pharmacogenetics guided anticoagulation.

http://www.wikidata.org/entity/Q37808224

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Pharmacogenetics guided anticoagulation.

@en

Pharmacogenetics guided anticoagulation.

@nl

type

label

Pharmacogenetics guided anticoagulation.

@en

Pharmacogenetics guided anticoagulation.

@nl

prefLabel

Pharmacogenetics guided anticoagulation.

@en

Pharmacogenetics guided anticoagulation.

@nl

P1433

Q37808224-6528029A-17F9-4EEF-9FD7-EF47C81857DF

P1476

Q37808224-E31606CC-E03C-45C0-9482-AA015F0370F9

P2860

Q37808224-0938F346-40A7-4B89-B2BA-C11E31BCA867

Q37808224-096039E1-7F23-4CB3-BCEA-16DD9E3BD587

Q37808224-0D6E1028-4E64-4BC1-A53B-89F17B71A78C

Q37808224-0FBD13A4-121B-4D95-9FE3-B7DE2E3CD4E2

Q37808224-1447E550-DE67-420F-8034-6BA1A3E42954

Q37808224-15566B41-81B6-4732-9304-440F3328900E

Q37808224-1F2262F5-8161-422B-B572-CCD9C38F733F

Q37808224-244BF53A-D7BD-4DAB-9AFF-42B785F6CD06

Q37808224-24771C9E-31F6-4CFA-BF3B-C7AB9486EC22

Q37808224-2737C794-FB3E-49A2-BA52-82F70B3CDA7C

P304

Q37808224-B5D3B9B9-0A01-41EF-ADAA-335D4D38B2B0

P31

Q37808224-57DDA94A-86F3-4A97-A03A-8BF5BDF81A79

P356

Q37808224-C69435CF-EFD7-4123-9BD5-F900903FCCDD

P478

Q37808224-4A200879-486F-4DE7-BC82-94DA557A58EF

P50

Q37808224-1D66746D-5779-4550-8122-58765808BCF6

Q37808224-F179B682-B566-43C7-9F4D-A393061D33AD

P577

Q37808224-C420E560-AA32-4B8B-8D82-6505E828F0C5

P698

Q37808224-DC340633-391B-46CA-A6CC-7E91FFAB838F

P921

Q37808224-5251A578-68F7-4B27-B3AA-DA067DE3AED5

P356

P1433

Clinical Chemistry and Laboratory Medicine

P1476

Pharmacogenetics guided anticoagulation.

@en

P2860

Clinical profile of prasugrel, a novel thienopyridine

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

PlA polymorphism and platelet reactivity following clopidogrel loading dose in patients undergoing coronary stent implantation

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Effects of P2Y(1) and P2Y(12) receptor antagonists on platelet aggregation induced by different agonists in human whole blood

Variability in platelet aggregation following sustained aspirin and clopidogrel treatment in patients with coronary heart disease and influence of the 807 C/T polymorphism of the glycoprotein Ia gene

Low-dose aspirin for the prevention of atherothrombosis

Aspirin and clopidogrel resistance: an emerging clinical entity

P304

S119-27

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1515/CCLM.2010.370

http://www.w3.org/2001/XMLSchema#string

P478

48 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

Christine Mannhalter

Raute Sunder-Plassmann

P577

2010-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21062219

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation